Stay up to date with the latest clinical business news in the industry!
- AI revolution in pharma: Qinecsa's James Bellamy unveils groundbreaking PV tech insights
- How Cure51’s AI breakthroughs are turning cancer into a manageable disease – an insider’s look
- Revolutionary Alzheimer's drug donanemab approved – what does this mean for the future of care?
- Third Arc Bio raises $165M series A to develop biologics for cancer and immunology
- Biologics driving M&A as Agilent snaps up specialist BIOVECTRA for $925 million
- IQVIA’s One Home for Sites: Reducing tech overload in clinical research
- Ask the experts: Should pharmacists take on more responsibility or is it a stretch too far?
- AI, patient engagement, and interoperability: Innovations shaping clinical trials
- Ensuring pharma data integrity: COPA-DATA’s automation solution tackles ALCOA challenges
- ViiV Healthcare's new data shows promising maternal and pregnancy outcomes for Apretude use